Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

被引:246
作者
Murata, K
Ishii, N
Takano, H
Miura, S
Ndhlovu, LC
Nose, M
Noda, T
Sugamura, K
机构
[1] Tohoku Univ, Sch Med, Dept Microbiol & Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan
[3] Ehime Univ, Sch Med, Dept Pathol 2, Shigenobu, Ehime 79102, Japan
[4] Inst Canc Res, Dept Cell Biol, Toshima Ku, Tokyo 170, Japan
关键词
OX40; ligand; antigen-presenting cell function; T cell printing; OX40 ligand mutant mice; cytokine;
D O I
10.1084/jem.191.2.365
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OX40 expressed on activated T cells is known to be an important costimulatory molecule on T cell activation in vitro. However, the in vivo functional significance of the interaction between OX40 and its ligand, OX40L, is still unclear. To investigate the role of OX40L during in vivo immune responses, we generated OX40L-deficient mice and a blocking anti-OX40L monoclonal antibody, MGP34. OX40L expression was demonstrated on splenic B cells after CD40 and anti-immunoglobulin (Ig)M stimulation, while only CD40 ligation was capable of inducing OX40L on dendritic cells. OX10L-deficient and MGP34-treated mice engendered apparent suppression of the recall reaction of T cells primed with both protein antigens and alloantigens and a significant reduction ill keyhole limper hemocyanin-specific Ige production. The impaired T cell priming was also accompanied by a concomitant reduction of both T helper type 1 (Th1) and Th2 cytokines. Furthermore; antigen-presenting cells (APCs) derived from the mutant mice revealed an impaired intrinsic APC function, demonstrating the importance of OX40L in both the printing and effector phases of T cell activation. Collectively, these results provide convincing evidence that OX40L, expressed on APCs, plays a critical role in antigen-specific T cell responses in vivo.
引用
收藏
页码:365 / 374
页数:10
相关论文
共 44 条
  • [1] Akiba H, 1999, J IMMUNOL, V162, P7058
  • [2] OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand
    AlShamkhani, A
    Birkeland, ML
    Puklavec, M
    Brown, MH
    James, W
    Barclay, AN
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) : 1695 - 1699
  • [3] MOLECULAR CHARACTERIZATION OF MURINE AND HUMAN OX40/OX40 LIGAND SYSTEMS - IDENTIFICATION OF A HUMAN OX40 LIGAND AS THE HTLV-1-REGULATED PROTEIN GP34
    BAUM, PR
    GAYLE, RB
    RAMSDELL, F
    SRINIVASAN, S
    SORENSEN, RA
    WATSON, ML
    SELDIN, MF
    BAKER, E
    SUTHERLAND, GR
    CLIFFORD, KN
    ALDERSON, MR
    GOODWIN, RG
    FANSLOW, WC
    [J]. EMBO JOURNAL, 1994, 13 (17) : 3992 - 4001
  • [4] Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO
  • [5] 2-8
  • [6] CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
  • [7] CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1
    Flynn, S
    Toellner, KM
    Raykundalia, C
    Goodall, M
    Lane, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) : 297 - 304
  • [8] Immune regulation by CD40 and its ligand GP39
    Foy, TM
    Aruffo, A
    Bajorath, J
    Buhlmann, JE
    Noelle, RJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 591 - 617
  • [9] IDENTIFICATION OF A HUMAN OX-40 LIGAND, A COSTIMULATOR OF CD4+ T-CELLS WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR
    GODFREY, WR
    FAGNONI, FF
    HARARA, MA
    BUCK, D
    ENGLEMAN, EG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) : 757 - 762
  • [10] Gramaglia I, 1998, J IMMUNOL, V161, P6510